About FDA

Office of Antimicrobial Products (OAP)


The Office of Antimicrobial Products is responsible for protecting the public health by assuring safe and effective drugs are available to the U.S. population for antimicrobials products (including antibacterial, antimycobacterial, antifungal, antiviral, and antiparasitic products), ophthalmology products, and products for the prevention of rejection in solid organ transplant recipients.

Immediate Office

Director: Edward M. Cox, M.D., MPH
Deputy Director: John Farley, M.D., MPH
Associate Director for Regulatory Affairs: Katherine Schuman
Associate Director for Research: Thushi Amini, Ph.D.
Associate Director for Regulatory Science: Sunita Shukla, MPH, PhD

Division of Anti-Infective Products (DAIP)

Director: Sumathi Nambiar, M.D., M.P.H.
Deputy Director: Dmitri Iarikov, M.D., Ph.D.

Division of Antiviral Products (DAVP)

Director: Debra Birnkrant, M.D.
Deputy Director: Jeffery Murray, M.D., M.P.H

Division of Transplant and Ophthalmology Products (DTOP)

Director: Ozlem Belen, M.D. M.P.H. (acting)

OAP Research Activities

Overview of research needs, requests for information (RFIs), public workshops/meetings, opportunities for collaboration, externally awarded research studies, and other important research. Overview of public workshops/meetings and available draft/final guidances.

OAP Regulatory Science Activities 

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Office of Antimicrobial Products
10903 New Hampshire Avenue
Silver Spring, MD 20993
Phone: (301) 796-1300
Fax: (301) 796-9887

Page Last Updated: 03/21/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English